Calyxt, Inc. (CLXT) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET

Company Participants

Bill Koschak - Chief Financial Officer

Michael Carr - President and Chief Executive Officer

Conference Call Participants

Bobby Burleson - Canaccord

Amit Dayal - H.C. Wainwright

Brian Wright - ROTH Capital Partners

Operator

Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to Calyxt’s First Quarter 2022 Earnings Result Conference Call and Webcast. [Operator Instructions] This conference is being recorded today, May 5, 2022. At this time, I would like to turn the conference over to Bill Koschak, Calyxt’s Chief Financial Officer. Please go ahead.

Bill Koschak

Thank you and good afternoon. This is Bill Koschak, the Chief Financial Officer of Calyxt. I would like to thank you for taking time to join us for Calyxt’s first quarter 2022 earnings results conference call and webcast. Presenting with me today is Michael A. Carr, our President and Chief Executive Officer. A press release detailing these results crossed the wire after today’s market close and is available on our company’s website, calyxt.com.

Before we begin the formal presentation, I’d like to remind everyone that statements made on the call and webcast, including those regarding future financial results and future operational goals and industry prospects are forward-looking and maybe subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the call. Please refer to the company’s SEC filings for a list of associated risks. This presentation also includes a discussion of adjusted net loss and adjusted net loss per share. Both are non-GAAP financial measures and in Calyxt’s press release and its SEC filings, each of which was posted on the company’s website at calyxt.com, you will find additional disclosure regarding these non-GAAP financial measures. References to these non-GAAP financial measures should be considered in addition to GAAP financial measures and should not be considered a substitute for results that are presented in accordance with GAAP. Lastly, this conference call is being webcast. The webcast link is available in the Investor Relations section of calyxt.com.

At this time, I would like to turn the call over to Michael for his opening remarks. Michael?

Michael Carr

Thank you, Bill and thank you for joining us on Calyxt’s earnings call today. For those of you who maybe getting up to speed with our story following our October 2021 announcement in which we repositioned Calyxt, I will take this moment to remind you we are a plant-based synthetic biology company committed to bringing the biomanufacturing capabilities of plants to innovative companies within our target end markets: the cosmeceutical, nutraceutical and pharmaceutical industries. Our technology platform, unique production capability and financial model are differentiated from other synthetic biology companies. I am pleased to report we are moving full-speed ahead into the growth and scaling phases of our organization’s development, with important expected milestones in 2022, which we will discuss on today’s call.